Reuters logo
BRIEF-Hikma buys assets of Bedford Laboratories for $300 mln
May 28, 2014 / 11:25 AM / 3 years ago

BRIEF-Hikma buys assets of Bedford Laboratories for $300 mln

May 28 (Reuters) - Hikma Pharmaceuticals Plc

* Hikma pharmaceutical - acquisition

* Signed an asset purchase agreement with Ben Venue Laboratories Inc., a member of Boehringer Ingelheim Group of Companies

* Deal for a total consideration of up to $300 million

* A further $75 million in contingent cash payments will be paid, subject to achievement of performance-related milestones, over a period of five years.

* Hikma has entered into an exclusivity arrangement with Boehringer Ingelheim Group to potentially acquire substantially all of assets of Ben Venue manufacturing facility in Bedford, Ohio

* Transaction highlights slightly dilutive to adjusted EPS in 2014 and 2015, with strong EPS accretion thereafter as acquired products are re- introduced to market Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below